Targeting of Histone Acetyltransferase p300 by Cyclopentenone Prostaglandin 螖12-PGJ2 through Covalent Binding to Cys1438
详细信息    查看全文
文摘
Inhibitors of histone acetyltransferases (HATs) are perceived to treat diseases like cancer, neurodegeneration, and AIDS. On the basis of previous studies, we hypothesized that Cys1438 in the substrate binding site could be targeted by 螖12-prostaglandin J2 (螖12-PGJ2), a cyclopentenone prostaglandin (CyPG) derived from PGD2. We demonstrate here the ability of CyPGs to inhibit p300 HAT-dependent acetylation of histone H3. A cell-based assay system clearly showed that the 伪,尾-unsaturation in the cyclopentenone ring of 螖12-PGJ2 was crucial for the inhibitory activity, while the 9,10-dihydro-15-deoxy-螖12,14-PGJ2, which lacks the electrophilic carbon (at carbon 9), was ineffective. Molecular docking studies suggested that 螖12-PGJ2 places the electrophilic carbon in the cyclopentenone ring well within the vicinity of Cys1438 of p300 to form a covalent Michael adduct. Site-directed mutagenesis of the p300 HAT domain, peptide competition assay involving p300 wild type and mutant peptides, followed by mass spectrometric analysis confirmed the covalent interaction of 螖12-PGJ2 with Cys1438. Using biotinylated derivatives of 螖12-PGJ2 and 9,10-dihydro-15-deoxy-螖12,14-PGJ2, we demonstrate the covalent interaction of 螖12-PGJ2 with the p300 HAT domain, but not the latter. In agreement with the in vitro filter binding assay, CyPGs were also found to inhibit H3 histone acetylation in cell-based assays. In addition, 螖12-PGJ2 also inhibited the acetylation of the HIV-1 Tat by recombinant p300 in in vitro assays. This study demonstrates, for the first time, that 螖12-PGJ2 inhibits p300 through Michael addition, where 伪,尾-unsaturated carbonyl function is absolutely required for the inhibitory activity.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700